Adenosine Therapeutics' Series C Round

Adenosine Therapeutics raised a round of funding on June 18, 2007. Investors include Novartis Venture Funds.

Adenosine Therapeutics develops pharmaceuticals related to the biochemical compound adenosine.…

Articles about Adenosine Therapeutics' Series C Round: